Alkermes plc
NASDAQALKS just reported Q2 results and the Street's reaction tells a split story: analysts are raising targets with unusual conviction, yet the stock fell 4.4% on the week to $50.50, leaving it well below where many of those fresh targets now sit. The analyst activity this week has been the most directionally consistent in months. Multiple firms lifted targets immediately following…
Snapshot as of 6 Aug 2026
ALKS just reported Q2 results and the Street's reaction tells a split story: analysts are raising targets with unusual conviction, yet the stock fell 4.4% on the week to $50.50, leaving it well below where many of…
Alkermes trades at $52.72 heading into its July 27 print, with short sellers retreating and analysts sharply split — the most interesting tension this week is not positioning but the widening gap between bullish…
Alkermes enters its July 27 earnings date with the short position meaningfully smaller than it was two weeks ago — a notable shift given that the prior note flagged shorts quietly rebuilding into the rally. Short…
Alkermes heads into its July 27 earnings date with an unusual tension: a stock up 29% in a month, a wave of analyst upgrades, and yet short sellers quietly adding to positions. The Street's direction of travel has been…
Alkermes enters the final week of June with a striking split: the stock has surged 30% in a month, analysts are chasing it higher with fresh target upgrades, yet a 10.4% short interest reading signals that a meaningful…
Alkermes entered May with a catalyst in hand. Q1 results dropped on May 5, topping both revenue and earnings estimates, and the stock responded with a 6% gain on the day. The question now is whether the renewed analyst…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ALKS — free to start on ORTEX.
Sign up for free →Open ALKS on ORTEX